XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.62+0.08 (+5.19%)
Close on Nov 17, 2026Market cap $15.33MP/E –Yield –
XTL Biopharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
XTL Biopharmaceuticals's market cap was $15.71M on Nov 11, 2026, against $29.37M a year earlier. Over the last 5 years it ranged from $15.23M to $63.54M, with a median of $32.26M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $15.71M | -23.2% |
| 2025 | Dec 31, 2025 | $20.45M | -53.7% |
| 2024 | Dec 31, 2024 | $44.15M | +100.6% |
| 2023 | Dec 29, 2023 | $22.02M | -16.5% |
| 2022 | Dec 30, 2022 | $26.37M | -54.9% |
| 2021 | Dec 31, 2021 | $58.52M | -6.1% |
| 2020 | Dec 31, 2020 | $62.32M | +121.2% |
| 2019 | Dec 31, 2019 | $28.18M | -20.8% |
| 2018 | Dec 31, 2018 | $35.58M | +41.8% |
| 2017 | Dec 29, 2017 | $25.09M | -25.1% |
| 2016 | Dec 30, 2016 | $33.47M | – |
See a number that looks wrong?